Heiko Lickert#
Photo: Matthias Tunger
| Membership Number: | 7034 |
| Membership type: | ORDINARY |
| Section: | CELL & DEVELOPMENTAL BIOLOGY |
| Elected: | 2024 |
| Main Country of Residence: | GERMANY |
| Homepage(s): | https://www.helmholtz-munich.de/en/idr/pi/heiko-lickert |
| ORCID: | 0000-0002-4597-8825 |
| Twitter: | @LickertHeiko |
Present and Previous Positions
- Since 2023 Co-founder of the Viacure GmbH, A spin-off company from Helmholtz Munich with the overall mission to target beta cell protection and regeneration for diabetes remission
- Since 2011 Director of the Institute of Diabetes and Regeneration Research (IDR), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Munich, Germany
- since 2011 W3 Professor and Chair of Beta Cell Biology, Medical Faculty, Technical University Munich (TUM) (‘German Elite University’), Munich, Germany
- 2009 - 2011 Tenured Group Leader, Endoderm Development and Regeneration group at Institute of Stem Cell Research, HMGU, Munich, Germany
- 2005 - 2009 Junior Group Leader/Senior Scientist, Endoderm Development and Regeneration group at Institute of Stem Cell Research, HMGU Germany
- 2002 - 2004 Postdoctoral Scientist at Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
Fields of Scholarship
- Beta cells
- Beta cell replacement
- Pancreas development
- Beta cell regeneration
- Pluripotent stem cell
- Diabetes
- Inceptor
- Combinatorial target therapy
- Islet biology
- Gene targeting
Honours and Awards
- 2023/24 Designated President of the German Stem Cell Network (GSCN)
- 2022 ERC Advanced Grant, European Research Council (ERC)
- 2021 One of the winners of the Falling Walls in the Life Sciences category
- 2021 m4 Award, Bayerisches Staatsministerium für Wirtschaft, Landesentwicklung und Energie
- 2020 PRO-SCIENTIA-Förderpreis der Eckhart-Buddecke-Stiftung
- 2020 Among the winners of Innovation Competition “Organ replacement from the lab” of the German Federal Ministry of Education and Research (BMBF) with the consortium “eISLET” Engineered Pancreatic Islets for Cell Replacement Therapies
- 2020 Werner-Creutzfeldt-Preis, Deutsche Diabetes Gesellschaft (DDG)
- 2019 Consortium “ISLET” Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe, European Commission
- 2018 "Verein der Freunde und Förderer" of the Helmholtz Zentrum München
- 2018 and 2011 Paula and Richard von Hertwig Award for Interdisciplinary Cooperation, HMGU
- 2017 “PanChip” Pancreas development and disease modelling on an iPSC chip platform, German Federal Ministry of Education and Research (BMBF)
- 2014 Human endoderm EU consortium: Up-scaling human insulin-producing beta cell production by efficient differentiation and expansion of pancreatic endoderm progenitors, European Commission
- 2010 - 2015 ERC Starting Grant European Research Council (ERC)
- 2005 - 2009 Emmy-Noether Junior Group, German Research Foundation (DFG)
- 2003 Otto-Hahn Medal, Max-Planck Society
- 2002 Hans-Spemann Award, Albert-Ludwigs University, Freiburg
